Nasal Devices
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/GB2008/003377, filed Oct 3, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,784,460 | Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 10,124,132 | Nasal Delivery In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 7,854,227 | Nasal Devices In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 10,112,021 | Intranasal Administration In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 10,737,045 | Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 10,398,859 | Nasal Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 10,765,829 | Delivery of Gases to the Nasal Airway In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 11,690,969 | Delivery of Gases to the Nasal Airway In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 10,639,438 | Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| US 11,602,603 | Nasal Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | ||
| 84 more patents in this group · Pro | ||||||
10 of 94 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 94, including 31 expired and 6 expiring within the 18 months from Nov 15, 2026.
26 of these are in force and held by Optinose Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.